Showing results (1591-1600 of 2,991) with videos related to
Sort By:
Pageof 300
Clinical Epigenetics|February 26, 2025
Imaging and outcome correlates of ctDNA methylation markers in prostate cancer: a comparative, cross-sectional [⁶⁸Ga]Ga-PSMA-11 PET/CT studyKilian Kluge, Vincent Lotz, Holger Einspieler, et al.Neuroradiology|May 28, 2026
Diagnostic accuracy of [99mTc]-Tc-HYNIC-PSMA-11 SPECT/CT in differentiating tumor recurrence from post-treatment changes in glioblastomaTahereh Ghaedian, Hamid Aghaei, Abbas Rakhsha, et al.Clinical Genitourinary Cancer|May 26, 2026
Androgen Receptor Pathway Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer Outside of Randomized Controlled Trials: A Systematic Review and Meta-Analysis of Prognostic Factors in Real-World AnalysesKeiichiro Miyajima, Takafumi Yanagisawa, Marcin Miszczyk, et al.Biotechnology Advances|May 11, 2023
Current and emerging applications of saccharide-modified chitosan: a critical reviewHamed Kazemi Shariat Panahi, Mona Dehhaghi, Hamid Amiri, et al.Urologic Oncology|July 14, 2007
Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohortsBahaa S Malaeb, Hani H Rashid, Yair Lotan, et al.World Journal of Urology|May 21, 2015
Molecular profile of urothelial carcinoma of the upper urinary tract: are pelvicalyceal and ureteral tumors different?Laura-Maria Krabbe, Aditya Bagrodia, Mary E Westerman, et al.BJU International|June 22, 2020
The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta-analysisReza Sari Motlagh, Keiichiro Mori, Noriyoshi Miura, et al.The Journal of Urology|February 10, 2004
Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomyShahrokh F Shariat, Seyed M Khoddami, Hossein Saboorian, et al.Journal of Personalized Medicine|November 27, 2021
Expression Analysis and Mutational Status of Histone Methyltransferase KMT2D at Different Upper Tract Urothelial Carcinoma LocationsEkaterina Laukhtina, Ursula Lemberger, Andreas Bruchbacher, et al.World Journal of Urology|June 18, 2011
Predictive factors of recurrence and survival of upper tract urothelial carcinomasGrégory Verhoest, Shahrokh F Shariat, Thomas F Chromecki, et al.Pageof 300